El-Koussi NA - Search Results

1

Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.

Abdel-Rahman HM, El-Koussi NA, Hassan HY. Abdel-Rahman HM, et al. Among authors: el koussi na. Arch Pharm (Weinheim). 2009 Feb;342(2):94-9. doi: 10.1002/ardp.200800113. Arch Pharm (Weinheim). 2009. PMID: 19173243

2

A novel dipeptide-based HIV protease inhibitor containing allophenylnorstatine.

Abdel-Rahman HM, el-Koussi NA, Alkaramany GS, Youssef AF, Kiso Y. Abdel-Rahman HM, et al. Among authors: el koussi na. Arch Pharm (Weinheim). 2004 Nov;337(11):587-98. doi: 10.1002/ardp.200400882. Arch Pharm (Weinheim). 2004. PMID: 15540219

3

Synthesis of 5-phenyl-1-(3-pyridyl)-1H-1,2,4-triazole-3-carboxylic acid derivatives of potential anti-inflammatory activity.

Rabea SM, El-Koussi NA, Hassan HY, Aboul-Fadl T. Rabea SM, et al. Among authors: el koussi na. Arch Pharm (Weinheim). 2006 Jan;339(1):32-40. doi: 10.1002/ardp.200500151. Arch Pharm (Weinheim). 2006. PMID: 16411174

4

Synthesis and antimicrobial activity of pyridines bearing thiazoline and thiazolidinone moieties.

Hassan HY, el-Koussi NA, Farghaly ZS. Hassan HY, et al. Chem Pharm Bull (Tokyo). 1998 May;46(5):863-6. doi: 10.1248/cpb.46.863. Chem Pharm Bull (Tokyo). 1998. PMID: 9621420

5

HIV protease inhibitors: peptidomimetic drugs and future perspectives.

Abdel-Rahman HM, Al-karamany GS, El-Koussi NA, Youssef AF, Kiso Y. Abdel-Rahman HM, et al. Curr Med Chem. 2002 Nov;9(21):1905-22. doi: 10.2174/0929867023368890. Curr Med Chem. 2002. PMID: 12369875 Review.

6

Brain delivery of HIV protease inhibitors.

Sheha MM, el-Koussi NA, Farag HH. Sheha MM, et al. Among authors: el koussi na. Arch Pharm (Weinheim). 2003 Mar;336(1):47-52. doi: 10.1002/ardp.200390003. Arch Pharm (Weinheim). 2003. PMID: 12666253

7

New pyrimidine/thiazole hybrids endowed with analgesic, anti-inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX-2/sEH dual inhibition.

Abdel-Aziz SA, Taher ES, Lan P, El-Koussi NA, Salem OIA, Gomaa HAM, Youssif BGM. Abdel-Aziz SA, et al. Among authors: el koussi na. Arch Pharm (Weinheim). 2022 Jul;355(7):e2200024. doi: 10.1002/ardp.202200024. Epub 2022 Apr 15. Arch Pharm (Weinheim). 2022. PMID: 35429006

8

Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile.

Abdel-Aziz SA, Taher ES, Lan P, Asaad GF, Gomaa HAM, El-Koussi NA, Youssif BGM. Abdel-Aziz SA, et al. Among authors: el koussi na. Bioorg Chem. 2021 Jun;111:104890. doi: 10.1016/j.bioorg.2021.104890. Epub 2021 Apr 8. Bioorg Chem. 2021. PMID: 33872924

9

Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.

Abdel-Hamid MK, Abdel-Hafez AA, El-Koussi NA, Mahfouz NM, Innocenti A, Supuran CT. Abdel-Hamid MK, et al. Among authors: el koussi na. Bioorg Med Chem. 2007 Nov 15;15(22):6975-84. doi: 10.1016/j.bmc.2007.07.044. Epub 2007 Aug 22. Bioorg Med Chem. 2007. PMID: 17822907

10

Cu (I) catalyzed alkyne-azide 1,3-dipolar cycloaddition (CuAAC): Synthesis of 17α-[1-(substituted phenyl)-1,2,3-triazol-4-yl]-19-nor-testosterone-17β-yl acetates targeting progestational and antipro-liferative activities.

Mohamed ZH, El-Koussi NA, Mahfouz NM, Youssef AF, Abdel Jaleel GA, Shouman SA. Mohamed ZH, et al. Among authors: el koussi na. Eur J Med Chem. 2015 Jun 5;97:75-82. doi: 10.1016/j.ejmech.2015.04.045. Epub 2015 Apr 28. Eur J Med Chem. 2015. PMID: 25942354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page